Tamsulosin Hydrochloride Capsule
Product Images NDC 0781-2076

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 0781-2076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure diagram of tamsulosin hydrochloride, showing its molecular composition and arrangement including functional groups and associated hydrochloride salt.*

FDA Label Image

Image 02

A line graph depicting plasma concentration (ng/mL) over time (hours) comparing tamsulosin hydrochloride under fasted and fed conditions. The graph shows a higher peak plasma concentration reached faster in the fasted state (dashed line) compared to the fed state (solid line), with both curves eventually declining over 36 hours.*

FDA Label Image

Image 03

A line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The graph compares treatment effects over approximately 13 weeks with symbols indicating different doses and placebo, illustrating trends in mean change across time points.*

FDA Label Image

Image 04

A line graph depicting mean change over a 13-week duration of treatment, comparing the effects of tamsulosin hydrochloride 0.4 mg, 0.8 mg, and placebo. The x-axis represents treatment duration in weeks, and the y-axis shows mean change values. The graph includes data points with different markers for each treatment group and a legend identifying them.*

FDA Label Image

Image 05

A line graph showing mean change in a measured variable (ml/sec) over a duration of up to 13 weeks and at last observation carried forward (LOCF). It compares treatment groups receiving 0.8 mg, 0.4 mg doses, and placebo, with data points connected by distinct lines and markers for each group.*

FDA Label Image

Image 06

A line graph showing mean change in mL/sec over duration of treatment in weeks for tamsulosin hydrochloride capsules at doses 0.4 mg, 0.8 mg, and placebo. The x-axis represents treatment duration from 0 to 13 weeks, while the y-axis shows mean change in flow rate. Different lines with symbols indicate each treatment group.*

FDA Label Image

Image 07

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, a human prescription drug by Sandoz Inc. The label states each capsule contains 0.4 mg of tamsulosin hydrochloride, includes dosage storage instructions, and indicates the package contains 100 capsules. The label shows NDC 0781-2076-01 and highlights safety warnings to keep out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.